Stanford’s Carolyn Bertozzi, 2022 Nobel Laureate in Chemistry, on translational science

Stanford’s newest Nobel laureate, Carolyn Bertozzi, details how fundamental science enabled her to invent bioorthogonal chemistry, a tool now used in therapies for cancer. She shares the $10 million Swedish kronor (about $1 million USD) prize equally with Morten Meldal, professor at University of Copenhagen; and K. Barry Sharpless, (who received his doctorate from Stanford in 1968), professor at Scripps Research, “for the development of click chemistry and bioorthogonal chemistry.”
Featured in this video:
Carolyn Bertozzi, the Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences, Baker Director of Sarafan ChEM-H, and Professor of Chemistry.
Christopher O. Barnes, Assistant Professor of Biology and Sarafan ChEM-H scholar

[@miraadi97]

Translational sciences with psychiatry is one of my interests in the future. Thanks for building it further ✍️❤️.

[@waynesimpson4081]

Congratulations also to Stanford, UC Berkeley, UCSF and even Lawrence Berkeley Lab.

[@emmanuelharbor2350]

Congratulations Carolyn Bertozzi!👊👊

[@dawneabdulal-bari9313]

Amazing 🌟 Congratulations on this impactful recognition of a most worthy body of work whose significance is monumental, especially in this post-COVID 19 pandemic reality 🏆

[@alinevillarrealmedina6994]

I loved the casual walk through the lab

[@michaelgonzalez9058]

Yes

[@davidwilkie9551]

Had to look up the definition.
What a very special technology to have.

[@kidsmash5867]

🎉🎉🎉congrats!!! Party on!

[@saykar0393]

Can this Bioorthogonal Chemistry contribute to achieve precision medicines and personalised therapies?

[@nirmalyaghosh7187]

❤❤❤❤❤

[@avinashkamble318]

👍👍👍👍👍

[@lordangelusmc]

no creo nada